NCT04461951

Brief Summary

Epidemiological evidence suggests that healthy diet is associated with a slowdown of cognitive decline leading to dementia, but the underlying mechanisms are still partially unexplored. Diet is the main determinant of gut microbiota' composition, which in turn impacts on brain structures and functions, however to date no studies on this topic are available. The goal of the present paper is to describe the design and methodology of the NutBrain Study aimed at investigating the association of dietary habits with cognitive function, and their role in modulating the gut microbiota composition, and brain measures as well. This is a population-based cohort study of community-dwelling adults aged 65 years or more living in Northern Milan, Italy. At the point of presentation people are screened for cognitive functions. Socio-demographic characteristics along with lifestyles and dietary habits, medical history, drugs, functional status, and anthropometric measurements are also recorded. Individuals suspected to have cognitive impairment at the screening phase undergo a clinical evaluation including a neurological examination and a Magnetic Resonance Imaging (MRI) scanning (both structural and functional). Stool and blood samples for the gut microbiota analysis and for the evaluation of putative biological markers are also collected. For each subject with a confirmed diagnosis of Mild Cognitive Impairment (MCI), two cognitively intact controls of the same sex and age are visited. The investigators intend to enrol at least 683 individuals for the screening phase and approximately 240 persons for the clinical assessment. The NutBrain is an innovative study that incorporates modern and advanced technologies (i.e. microbiome and neuroimaging) into traditional epidemiologic design. The study represents a unique opportunity to address key questions about the role of modifiable risk factors on cognitive impairment, with a particular focus on dietary habits and their association with gut microbiota and markers of the brain-aging process. These findings will help to encourage and plan lifestyle interventions, for both prevention and treatment, aiming at promoting healthy cognitive ageing.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
643

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2019

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

June 29, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 8, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

July 8, 2020

Status Verified

July 1, 2020

Enrollment Period

2.5 years

First QC Date

June 29, 2020

Last Update Submit

July 7, 2020

Conditions

Keywords

Cognitive Impairments, Dietary habits, Gut Microbiota, Brain

Outcome Measures

Primary Outcomes (1)

  • Number of participants with Mild Cognitive Impairment (MCI) in community dwelling older adults

    Measured using a battery of well-established neuropsychological tests exploring global cognitive function (Mini Mental State Examination-MMSE) and different cognitive domains: memory (Free and Cues Selective Reminding Test (FCSRT), Logical memory test - Babcock Test, the Rey-Osterrieth Complex Figure Test (ROCF) - delay recall, executive function (Frontal Assessment Battery (FAB)), phonemic and semantic verbal fluency, Trial Making Test (TMT), language (Picture Naming Test), visuo-spatial abilities (Rey-Osterrieth Complex Figure Test (ROCF) - copy). All the test scores are corrected for age, sex, and education and compared with the values available for the Italian population. Diagnosis follows the Albert criteria.

    Screening evaluation at T=2 (24 months after T=0)

Secondary Outcomes (2)

  • Brain MRI measures

    Clinical evaluation at T=3 (32 months after T=0)

  • Bacterial composition of stool samples in terms of relative abundance

    Clinical evaluation at T=3 (32 months after T=0)

Study Arms (1)

Community dwelling seniors

Participants are visited at the research facility in their residence town by a trained team. Informed consent form is completed at the research facility prior to data collection. In those individuals without capacity to give full informed consent, proxy consent is collected from relatives or caregivers. This 2-hours interview includes a face-to-face administration of a neuropsychological battery of tests and questionnaires to inquire about socio-demographic, occupational, and social-economic data, education, medical conditions and drug use, lifestyle habits, functional status, and dietary behaviours.

Other: Lifestyles (exposure)

Interventions

no intervention

Also known as: no intervention
Community dwelling seniors

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

This is a population-based cohort study of community-dwelling adults aged 65 years or more living in Northern Milan, Italy (Bollate and Baranzate municipalities). A random sample is drawn from the official register of residents in the two municipalities. Eligible population is contacted by means of a letter of invitation, in which people are invited to contact the ITB-CNR by phone to schedule the first visit during which he/she is asked to bring last instrumental and clinical exams prescribed by their general practitioner.

You may qualify if:

  • attending a medical appointment in the research facility
  • living at home in one of the two municipalities
  • being 65+ years

You may not qualify if:

  • i) neuropsychological criteria:
  • subject with dementia, pre-existing cognitive impairment (e.g. aphasia, neglect), concomitant severe psychiatric disease, others neurological conditions (e.g. severe depression and behavioral disorders)
  • severe sensory disturbances (e.g. auditory and/or visual loss) that do not allow completing neuropsychological assessment
  • ii) microbiota' analysis protocol:
  • individuals with artificial nutrition in progress
  • history of active uncontrolled gastrointestinal disorders or diseases (inflammatory bowel disease, ulcerative colitis, and Crohn's disease)
  • subjects who underwent previous major surgery on the gastro-enteric tract, with the exception of cholecystectomy and appendectomy, in the past five years
  • use of antibiotics or large doses of commercial probiotics in the 4 weeks prior the visit
  • subjects under radio-chemo-therapy
  • iii) MRI scanning protocol:
  • subjects with metal fragments in the body, surgically implanted devices containing metal
  • severe claustrophobia
  • inability to lie down in the MRI scanner for the duration of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Struttura Semplice Neuropsicologia Clinica/ Centro UVA

Pavia, 27100, Italy

RECRUITING

Related Publications (4)

  • Perdixi E, Cotta Ramusino M, Costa A, Bernini S, Conti S, Jesuthasan N, Severgnini M, Prinelli F; NutBrain Study Group. Polypharmacy, drug-drug interactions, anticholinergic burden and cognitive outcomes: a snapshot from a community-dwelling sample of older men and women in northern Italy. Eur J Ageing. 2024 Mar 29;21(1):11. doi: 10.1007/s10433-024-00806-0.

  • Bernini S, Conti S, Perdixi E, Jesuthasan N, Costa A, Severgnini M, Ramusino MC, Prinelli F; NutBrain Study Group. Investigating the individual and joint effects of socioeconomic status and lifestyle factors on mild cognitive impairment in older Italians living independently in the community: results from the NutBrain study. J Nutr Health Aging. 2024 Mar;28(3):100040. doi: 10.1016/j.jnha.2024.100040. Epub 2024 Jan 26.

  • Perdixi E, Bernini S, Conti S, Jesuthasan N, Cotta Ramusino M, Costa A, Prinelli F. Pre-existing mental health disorders and fear of COVID-19 pandemic: Data from a phone survey in community-dwelling older adults recruited in the NutBrain study. Front Psychiatry. 2022 Nov 7;13:995308. doi: 10.3389/fpsyt.2022.995308. eCollection 2022.

  • Prinelli F, Jesuthasan N, Severgnini M, Musicco M, Adorni F, Correa Leite ML, Crespi C, Bernini S. Exploring the relationship between Nutrition, gUT microbiota, and BRain AgINg in community-dwelling seniors: the Italian NutBrain population-based cohort study protocol. BMC Geriatr. 2020 Jul 23;20(1):253. doi: 10.1186/s12877-020-01652-2.

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Blood and stool samples are collected from each participant and stored in the biorepository at the Hospital for gut microbiota analysis and the evaluation of putative biological markers.

MeSH Terms

Conditions

Cognitive DysfunctionFeeding Behavior

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersBehavior, AnimalBehavior

Study Officials

  • Federica Prinelli, PhD

    IRCCS C. Mondino Foundation

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Federica Prinelli, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2020

First Posted

July 8, 2020

Study Start

April 1, 2019

Primary Completion

October 1, 2021

Study Completion

April 1, 2022

Last Updated

July 8, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations